BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
BioMarin Pharmaceutical reports 2020 executive compensation
By ExecPay News
Published: April 13, 2021
BioMarin Pharmaceutical reported fiscal year 2020 executive compensation information on April 13, 2021.
In 2020, seven executives at BioMarin Pharmaceutical received on average a compensation package of $7M, a 6% decrease compared to previous year.
Average pay of disclosed executives at BioMarin Pharmaceutical
Jean-Jacques Bienaim, Chief Executive Officer, received $18M in total, which decreased by 2% compared to 2019. 64% of Bienaim's compensation, or $12M, was in stock awards. Bienaim also received $1.7M in non-equity incentive plan, $3.4M in option awards, $1.3M in salary, as well as $96K in other compensation.
For fiscal year 2020, the median employee pay was $181,141 at BioMarin Pharmaceutical. Therefore, the ratio of Jean-Jacques Bienaim's pay to the median employee pay was 100 to one.
Henry J. Fuchs, President, Worldwide R&D, received a compensation package of $7.5M, which increased by 6% compared to previous year. 63% of the compensation package, or $4.7M, was in stock awards.
C. Greg Guyer, Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations, earned $6.3M in 2020.
Brian R. Mueller, Chief Financial Officer, received $5.8M in 2020, which increases by 248% compared to 2019.
Robert A. Baffi, Former President of Global Manufacturing and Technical Operations, earned $4.7M in 2020, a 28% decrease compared to previous year.
Jeff Ajer, Executive Vice President, Chief Commercial Officer, received $4.5M in 2020, which decreases by 28% compared to 2019.
Daniel Spiegelman, Chief Financial Officer, earned $2.3M in 2020, a 56% decrease compared to previous year.
Related executives
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
You may also like
Source: SEC filing on April 13, 2021.